| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11060-016-2210-1 |
| P698 | PubMed publication ID | 27401155 |
| P50 | author | Jacob Y Shin | Q80338203 |
| P2093 | author name string | Aidnag Z Diaz | |
| P2860 | cites work | Presentation, management, and outcome of elderly patients with newly-diagnosed anaplastic astrocytoma. | Q46071407 |
| Prognostic significance of surgery and radiation therapy in cases of anaplastic astrocytoma: retrospective analysis of 170 cases | Q48204627 | ||
| Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy | Q48661262 | ||
| IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy. | Q55460980 | ||
| Effects of health insurance and race on colorectal cancer treatments and outcomes | Q73184812 | ||
| The 2007 WHO classification of tumours of the central nervous system | Q24685772 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012. | Q30373363 | ||
| Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402. | Q30542081 | ||
| Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404. | Q33198814 | ||
| The genetic landscape of anaplastic astrocytoma | Q33688888 | ||
| Increasing radiation dose intensity using hyperfractionation in patients with malignant glioma. Final report of a prospective phase I-II dose response study | Q34239497 | ||
| Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. | Q34446549 | ||
| The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma | Q34498352 | ||
| Survival of patients treated with radiation therapy for anaplastic astrocytoma | Q34503896 | ||
| Anaplastic astrocytoma in adults. | Q34579207 | ||
| The impact of health insurance status on the survival of patients with head and neck cancer | Q34904613 | ||
| Survival following adjuvant PCV or temozolomide for anaplastic astrocytoma | Q35800632 | ||
| Anaplastic astrocytoma: diagnosis, prognosis, and management | Q35924431 | ||
| A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party | Q35993865 | ||
| Radiotherapy and temozolomide in anaplastic astrocytoma: a retrospective multicenter study by the Central Nervous System Study Group of AIRO (Italian Association of Radiation Oncology). | Q36010125 | ||
| Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989 | Q36053232 | ||
| The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide | Q36676389 | ||
| Meta-analysis of glioblastoma multiforme versus anaplastic astrocytoma identifies robust gene markers. | Q37346035 | ||
| A 16-gene signature distinguishes anaplastic astrocytoma from glioblastoma | Q37514165 | ||
| Outcomes for patients with anaplastic astrocytoma treated with chemoradiation, radiation therapy alone or radiation therapy followed by chemotherapy: a retrospective review within the era of temozolomide | Q38092769 | ||
| Differential expression of HIF-1 in glioblastoma multiforme and anaplastic astrocytoma | Q40051006 | ||
| The Effect of Payer Status on Survival of Patients with Stage I/II Non-small Cell Lung Cancer: NCDB 1998-2011. | Q40153530 | ||
| NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide | Q43245397 | ||
| The impact of socioeconomic status on survival after cancer in the United States : findings from the National Program of Cancer Registries Patterns of Care Study | Q43783526 | ||
| Long-term follow-up in managing anaplastic astrocytoma by multimodality approach with surgery followed by postoperative radiotherapy and PCV-chemotherapy: phase II trial | Q44012366 | ||
| Anaplastic astrocytoma | Q44125195 | ||
| P433 | issue | 3 | |
| P921 | main subject | anaplastic astrocytoma | Q486092 |
| P304 | page(s) | 557-565 | |
| P577 | publication date | 2016-07-11 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Anaplastic astrocytoma: prognostic factors and survival in 4807 patients with emphasis on receipt and impact of adjuvant therapy | |
| P478 | volume | 129 |
Search more.